What are the treatment options for seborrheic keratosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Seborrheic Keratosis Treatment

Primary Treatment Recommendation

For seborrheic keratosis, cryotherapy is the first-line treatment when removal is desired, though no treatment is medically necessary as these are benign lesions. 1

When to Treat

  • Seborrheic keratoses are biologically benign and do not require removal for medical reasons unless histologic confirmation is needed or lesions become traumatized/symptomatic 1
  • Most patients seek treatment for cosmetic concerns, particularly when lesions appear on the face 1, 2
  • Among patients presenting to dermatologists, approximately 43% undergo treatment for lesion removal 1

Treatment Options by Modality

Cryotherapy (Most Common)

  • Cryosurgery is the most commonly employed removal method by dermatologists 1
  • Widely used but requires careful patient selection to optimize cosmetic results, particularly in patients with skin of color 1

Surgical Methods

  • Shave excision, electrodesiccation, and curettage (or combinations) are effective alternatives to cryotherapy 1, 2
  • These procedures can effectively remove lesions but carry potential drawbacks including post-procedure depigmentation, scarring, and recurrence 3
  • Curettage under local anesthesia is considered a safe method for eradication 3

Laser Therapy

  • Laser application represents another treatment option, though it may cause similar side effects as other destructive methods 2, 3

Emerging Topical Treatments

  • Topical calcipotriol 0.005% ointment shows promise for flat seborrheic keratoses on the face, with complete regression achieved in 3-8 months and remission lasting 6-10 years in case series 4
  • Topical keratolytics and vitamin D analogues are being investigated 5
  • Currently, no FDA-approved topical therapeutic agent exists for seborrheic keratosis, representing an unmet clinical need 1, 5

Novel Technologies

  • Nanosecond-pulsed electric field technology is a promising new technique with fewer side effects compared to traditional destructive methods 3

Important Clinical Considerations

Patient Selection Factors

  • Lesion location matters: Facial lesions require particular attention to cosmetic outcomes 1, 2
  • Lesion characteristics: Thick or numerous lesions may be more challenging to treat with certain modalities 1
  • Skin type: Patients with darker skin types are at higher risk for post-treatment pigmentary changes with destructive methods 1

Common Pitfalls to Avoid

  • Failing to confirm the diagnosis when clinical presentation is atypical - consider dermatoscopy or biopsy to exclude malignancy 2
  • Using aggressive destructive techniques without considering cosmetic outcomes, particularly on the face or in darker skin types 1
  • Not discussing that treatment is elective - patients should understand these are benign lesions with no medical necessity for removal 1, 2

Diagnostic Confirmation

  • Diagnosis is usually made clinically 2
  • Dermatoscopy serves as a noninvasive diagnostic technique to differentiate seborrheic keratosis from other benign and malignant tumors 3
  • Histology should be obtained when clinical diagnosis is uncertain 1

Epidemiology Context

  • Seborrheic keratosis affects approximately 83 million Americans, making it the most common benign epidermal tumor 1, 5
  • Dermatologists diagnose an average of 155 patients per month with seborrheic keratosis 1
  • Among presenting patients, 33% have more than 15 lesions while 67% have 15 or fewer lesions 1

References

Research

Seborrheic keratosis.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.